(1995). AP: The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim Biophys Acta
(2007). Bandyopadhyay D: MUC1: a target molecule for cancer therapy. Cancer Biol Ther
(2010). et al: Analysis of cell type-specific expression of CK1 epsilon in various tissues of young adult BALB/c Mice and in mammary tumors of SV40 T-Agtransgenic mice.
(2008). et al: Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res
(2003). et al: Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Res
(2009). et al: Detection of different tumor growth kinetics in single transgenic mice with oncogene-induced mammary carcinomas by flat-panel volume computed tomography.
(2006). et al: Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
(2009). et al: Ductal carcinoma in situ: state of the science and roadmap to advance the field.
(2004). et al: Genomewide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis.
(2000). et al: Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system.
(2007). et al: Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene
(2002). et al: Microcalcifications of breast cancer and atypical cystic lobules associated with infiltration of foam cells expressing osteopontin. Virchows Arch
(2005). et al: Molecular imaging of breast cancer in a transgene mouse model. Chirurgisches Forum
(2003). et al: NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization.
(1998). et al: Osteopontin expression in a group of lymph node negative breast cancer patients.
(2003). et al: The case for early detection. Nat Rev Cancer
(2007). et al: The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma. Histopathology
(2008). et al: Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.
(2006). et al: X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell
(2001). Expression of epithelial mucins
(2005). Follettie MT: Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res
(2003). Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA
(2000). Genetically engineered mouse models of mammary intraepithelial neoplasia.
(2004). Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia
(1986). Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase. Mol Cell Biol
(1994). JT: Identification of genes expressed in premalignant breast disease by microscopy-directed cloning.
(2008). Kuerer HM: The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer
(2008). Kuo PC: Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev
(2004). Liskay RM: EXO1-A multi-tasking eukaryotic nuclease. DNA Repair (Amst)
(2008). MV: Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE
(2008). Osteopontin expression profiles predict pathological and clinical outcome in breast cancer. Anticancer Res
(2006). Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res
(2008). Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev
(2002). Roche PC: Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR. Breast Cancer Res Treat
(2005). S: What makes MUC1 a tumor antigen? Tumour Biol
(1983). Sato A: Regulation of ribonucleotide reductase activity in mammalian cells. Mol Cell Biochem
(2001). Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
(2009). Silver A: The opposing roles of Wnt-5a in cancer.